Cell Cycle
-
RAD51 Inhibitor B02
Catalog No. A18334 RAD51 inhibitorAD51 Inhibitor B02 (B02) is an inhibitor of human RAD51 with an IC50 of 27.4 μM. 了解更多 -
360A iodide
Catalog No. A14976 -
Pyridostatin
Catalog No. A12717 Pyridostatin是一种G-quadruplexe稳定剂,无细胞试验中Kd为490 nM,其以一系列原癌基因,包括c-kit,K-ras 和 Bcl-2为靶点。可通过诱导复制和转录依赖性DNA损伤来促进人类癌细胞的生长停滞。 了解更多 -
ID 8
Catalog No. A12922 -
AZ191
Catalog No. A14314 -
Mirk-IN-1
Catalog No. A16255 -
LDN-192960 hydrochloride
Catalog No. A21390 DYRK2 inhibitorLDN-192960 hydrochloride is an inhibitor of Haspin and Dual-specificity Tyrosine-regulated Kinase 2 (DYRK2) with IC50s of 10 nM and 48 nM, respectively. 了解更多 -
Zoledronic Acid
Catalog No. A11010 osteoclastic bone resorption 抑制剂Zoledronic acid, 破骨细胞抑制剂,通过抑制甲羟戊酸途径诱导破骨细胞凋亡。 了解更多 -
Azathioprine
Catalog No. A10107 Azathioprine是一种免疫抑制药物,可抑制嘌呤合成和GTP结合蛋白Rac1活化,用于治疗器官移植和自身免疫性疾病。 了解更多 -
GGTI-2418
Catalog No. A13112 -
Balamapimod (MKI-833)
Catalog No. A13119 -
K-Ras(G12C) inhibitor 6
Catalog No. A14103 K-Ras(G12C) 抑制剂K-Ras(G12C) inhibitor 6 是致癌性K-Ras(G12C)的不可逆抑制剂,颠覆了天然核苷酸的偏爱性,使GDP优于GTP。 了解更多 -
K-Ras(G12C) inhibitor 12
Catalog No. A14227 -
6H05 (trifluoroacetate salt)
Catalog No. A14235 -
K-Ras(G12C) inhibitor 9
Catalog No. A14250 -
NSC-23766 HCl
Catalog No. A13975 Rac GTPase 抑制剂NSC 23766是Rac特异性GEF TrioN和Tiam 1(IC50 = 50 uM)引起的Rac1激活的细胞可渗透性可逆抑制剂。 了解更多 -
Salirasib
Catalog No. A11572 -
XRP44X
Catalog No. A16049 -
APS-2-79 HCl
Catalog No. A16175 KSR/Ras 抑制剂APS-2-79 HCl,稳定KSR(Ras激酶抑制剂)失活状态并拮抗致癌性Ras信号(IC50值为120 nM,对抗KSR2的ATP-生物素探针标记)的小分子。 了解更多 -
BQU57
Catalog No. A14956 -
ARS-1620
Catalog No. A16809 -
Antineoplaston A10
Catalog No. A17183 -
-
最新产品
Ras-IN-3144
Catalog No. A17222 pan-RAS inhibitorRas-IN-3144 is a pan-RAS inhibitor which inhibits RAS signaling pathways in cancer cells and prevents the growth of RAS mutant mouse cancer xenografts. 了解更多 -
-
AMG-510 racemate
Catalog No. A18752 KRAS G12C covalent inhibitorAMG-510 is a potent, orally bioavailable, and selective KRAS G12C covalent inhibitor with anti-tumor activity. 了解更多 -
ZT-12-037-01
Catalog No. A18395 ATP-competitive STK19 inhibitorZT-12-037-01 is a potent, selective, ATP-competitive STK19 inhibitor. ZT-12-037-01 effectively blocks oncogenic NRAS-driven melanocyte malignant transformation and melanoma growth in vitro and in vivo. 了解更多 -
KRAS G12C inhibitor 13
Catalog No. A19041 KRAS G12C inhibitorKRAS G12C inhibitor 13 is a KRAS G12C inhibitor extracted from patent WO2018143315A1, compound 30. 了解更多 -
KRAS G12C inhibitor 5
Catalog No. A18840 KRas G12C inhibitorKRAS G12C inhibitor 5 is a KRas G12C inhibitor extracted from patent WO2017201161A1, Compound example 147. 了解更多 -
KRAS G12C inhibitor 15
Catalog No. A18447 KRAS G12C inhibitorKRAS G12C inhibitor 15 is a potent KRAS G12C inhibitor extracted from patent WO2019110751A1, compound 22, has an IC50 of 5 nM. 了解更多 -
KRAS G12C inhibitor 16
Catalog No. A18444 KRAS G12C inhibitorKRAS G12C inhibitor 16 is a potent KRAS G12C inhibitor extracted from patent WO2019110751A1, compound 39, has an IC50 of 97 nM. 了解更多 -
KRAS G12C inhibitor 17
Catalog No. A18441 KRAS G12C inhibitorKRAS G12C inhibitor 17 is a potent KRAS G12C inhibitor extracted from patent WO2019110751A1, compound 82, has an IC50 of 5 nM. 了解更多 -
MK-1775
Catalog No. A10599